在多基因风险评分基础上联合常规病例发现策略识别未诊断的慢性阻塞性肺疾病
该横断面分析纳入FHS和COPDGene两个观察性研究中35岁以上、无医生诊断COPD史的参与者,评估COPD多基因风险评分(PRS)联合改良肺功能问卷(mLFQ)对肺功能定义的中重度COPD的识别价值。在FHS和COPDGene非西班牙裔白人参与者中,PRS联合mLFQ较单用mLFQ显著提高曲线下面积;在10%转诊阈值下,FHS中联合策略正确重分类13.8%的COPD病例,但COPDGene中未见此效果。作者结论认为PRS可增强一般人群中未诊断COPD的识别,需进一步研究评估其对诊断和结局的影响。
要点
- 在FHS中,PRS联合mLFQ较单用mLFQ显著提高AUC(0.78升至0.84,P<.001)。
- 在COPDGene非西班牙裔白人中,联合策略同样显著提高AUC(0.75升至0.78,P<.001)。
- 在10%转诊阈值下,FHS中联合策略正确重分类13.8%的COPD病例,COPDGene中未见此效果。
核心结论
- COPD多基因风险评分可增强一般人群中未诊断COPD的识别,优于常规病例发现策略。
- 作者指出需进一步研究评估该策略对COPD诊断和结局的影响。
研究设计与样本
- 该研究为横断面分析,使用FHS和COPDGene两个观察性研究的数据。
- 纳入35岁及以上、报告无医生诊断COPD史的参与者。
- FHS为社区队列,COPDGene为COPD富集队列。
主要发现
- FHS纳入3385人(中位年龄52.0岁,45.9%男性),其中160人(4.7%)存在肺功能定义COPD。
- COPDGene纳入4095人(中位年龄56.8岁,55.5%男性),其中775人(18.9%)存在肺功能定义COPD。
- PRS联合mLFQ较单用mLFQ的AUC:FHS从0.78升至0.84(P<.001),COPDGene非西班牙裔非洲裔从0.69升至0.72(P=.04),COPDGene非西班牙裔白人从0.75升至0.78(P<.001)。
- 在10%肺功能转诊风险阈值下,FHS中联合策略正确重分类13.8%(95%CI,6.6%-21.0%)的COPD病例,COPDGene中未见此效果。
关键数值与推荐
- 主要结局为肺功能定义的中重度COPD:FEV1/FVC<0.7且FEV1占预计值<80%。
- 采用逻辑回归模型评估PRS、mLFQ评分及两者联合对COPD的预测性能。
- 转诊肺功能检查的风险阈值设为10%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Chronic obstructive pulmonary disease (COPD) is often undiagnosed. Although genetic risk plays a significant role in COPD susceptibility, its utility in guiding spirometry testing and identifying undiagnosed cases is unclear. OBJECTIVE: To determine whether a COPD polygenic risk score (PRS) enhances the identification of undiagnosed COPD beyond a case-finding questionnaire (eg, the Lung Function Questionnaire) using conventional risk factors and respiratory symptoms. DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional analysis of participants 35 years or older who reported no history of physician-diagnosed COPD was conducted using data from 2 observational studies: the community-based Framingham Heart Study (FHS) and the COPD-enriched Genetic Epidemiology of COPD (COPDGene) study. EXPOSURES: Modified Lung Function Questionnaire (mLFQ) scores and COPD PRS. MAIN OUTCOMES AND MEASURES: The primary outcome was spirometry-defined moderate to severe COPD (forced expiratory volume in the first second of expiration/forced vital capacity [FEV1/FVC] <0.7 and FEV1 [percent predicted] <80%). The performance of logistic models was assessed using the PRS, mLFQ score, and PRS plus mLFQ score for predicting spirometry-defined COPD. RESULTS: Among 3385 FHS participants (median age, 52.0 years; 45.9% male) and 4095 COPDGene participants (median age, 56.8 years; 55.5% male) who reported no history of COPD, 160 (4.7%) FHS and 775 (18.9%) COPDGene participants had spirometry-defined COPD. Adding the PRS to the mLFQ score significantly improved the area under the curve from 0.78 to 0.84 (P < .001) in FHS, 0.69 to 0.72 (P = .04) in COPDGene non-Hispanic African American, and 0.75 to 0.78 (P < .001) in COPDGene non-Hispanic White participants. At a risk threshold for spirometry referral of 10%, the addition of the PRS to the mLFQ score correctly reclassified 13.8% (95% CI, 6.6%-21.0%) of COPD cases in FHS, but not in COPDGene. CONCLUSIONS AND RELEVANCE: A COPD PRS enhances the identification of undiagnosed COPD beyond a conventional case-finding approach in the general population. Further research is needed to assess its impact on COPD diagnosis and outcomes.
引用
- Zhang J, Hobbs BD, Silverman EK, et al. Polygenic Risk Score Added to Conventional Case Finding to Identify Undiagnosed Chronic Obstructive Pulmonary Disease. JAMA. 2025. PMID: 39841442. doi:10.1001/jama.2024.24212
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。